Glucosamine Versus MSM for Dog Joint Pain: What Actually Helps First

By Justin Shmalberg, DVM, CVA, ACVN, ACVSMR

Comparisons · August 10, 2026 · 7 min read

Glucosamine and MSM tackle a dog's joint pain differently, and knowing which one to reach for first actually matters.

Is Glucosamine or MSM the Right First Move?

Sadie was an 8-year-old Border Collie, 42 pounds, the kind of dog who used to clear a coffee table jump without thinking about it. Her owner noticed the change on a Tuesday in early spring: Sadie stood up from her afternoon nap on the hardwood floor, held her weight oddly on the left hind leg for three or four steps, and then walked it off. It happened again that weekend, after a longer hike. Nothing dramatic — no yelp, no limp that lasted more than a minute — but her owner had raised two other dogs into their teens and knew what the first quiet season of joint trouble looks like. She came into my exam room with a question I hear almost weekly in one form or another: glucosamine, MSM, or both? She’d read both names on the same supplement label and had no idea which one was actually doing the work, or whether either was worth the cost given Sadie’s otherwise clean bill of health.

That’s the honest starting point for this comparison. Glucosamine and MSM (methylsulfonylmethane) get sold together constantly, but they are not the same ingredient doing the same job, and the evidence behind each one is not equally strong.

What Glucosamine Actually Does Once It’s Swallowed

Glucosamine is an amino sugar your dog’s body already makes and uses to build the cartilage matrix — it’s a raw material for the glycosaminoglycans that give cartilage its cushioning structure. The theory is straightforward: supply more raw material, support cartilage repair, slow the grind of osteoarthritis. The clinical reality is messier. A review titled Glucosamine and chondroitin use in canines for osteoarthritis: A review, published on PubMed, describes “limited and conflicting evidence” for glucosamine and chondroitin in dogs despite how routinely they’re recommended, and points to a real shortage of well-designed canine trials.

Not every study is a wash. A Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis: randomised double-blind, positive-controlled trial comparing glucosamine/chondroitin sulfate against carprofen in osteoarthritic dogs found statistically significant improvements in pain, weight-bearing, and severity scores by day 70 — though the response came on slower than the drug did. A more recent trial in dogs with hip osteoarthritis, the Study of the Effectiveness of Glucosamine and Chondroitin Sulfate, Marine-Based Fatty Acid Compounds, and Carprofen for the Treatment of Dogs with Hip Osteoarthritis: Study of the Effectiveness of Glucosamine and Chondroitin Sulfate, Marine-Based Fatty Acid Compounds, and Carprofen published in PMC, found the opposite for glucosamine specifically: increases in peak vertical force (a gait-based measure of how much weight a dog puts on a limb) were not significantly greater than placebo at four and six weeks, while the marine fatty acid compounds and carprofen groups did significantly improve. Two well-controlled trials, two different answers — that inconsistency is the honest shape of the glucosamine evidence base.

Where MSM Fits — and Where the Evidence Runs Thin

MSM supplies bioavailable sulfur, which the body uses in collagen cross-linking and connective tissue synthesis, and it’s often framed as reducing the inflammatory signaling that drives joint discomfort. The mechanism is plausible and the sulfur-collagen connection is real chemistry, not marketing fiction. What’s thinner is dog-specific trial data. Most of the controlled, randomized evidence for MSM’s effect on joint pain comes from human medicine — a Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial: Randomized, Double-Blind, Placebo-Controlled Trial in people with mild knee pain found MSM supplementation improved knee-related quality-of-life scores over placebo. That’s a human study, not a canine one, and I don’t extrapolate human dosing or outcomes onto dogs — different metabolism, different trial population. It tells us MSM has a real physiologic effect worth taking seriously; it doesn’t tell us the size of that effect in an arthritic Labrador.

The Case for Combining Them, and the Counterargument I Take Seriously

Here’s where I land, and I’ll name the pushback first because it’s a fair one: if the canine glucosamine data is genuinely mixed and the MSM data is mostly borrowed from human trials, why recommend either? The counterargument is that you’re spending money and pill burden on a combination with no dog-specific proof of additive benefit.

I still recommend a combination product for most dogs starting mobility support, and here’s the reasoning. The mechanisms are complementary rather than redundant — one is a cartilage-matrix substrate, the other is a sulfur donor and proposed anti-inflammatory — so there’s biological plausibility for them working on different parts of the same problem rather than competing for the same effect. And the randomised positive-controlled trial showing real gait and pain-score improvement used a glucosamine/chondroitin combination, not glucosamine alone, which matters when you’re deciding what to actually buy. What I don’t do is promise an owner that a joint supplement will reverse osteoarthritis or replace a diagnosis. A review in the Journal of Small Animal Practice on non-pharmaceutical treatments for canine osteoarthritis is consistent with what I see clinically: supplements are one piece of a multimodal plan, alongside weight management and appropriate exercise, not a standalone fix. If you’re trying to figure out whether what you’re seeing is early osteoarthritis or just normal aging stiffness in the first place, that distinction changes how urgently any of this matters — our guide on arthritis versus normal aging stiffness in dogs walks through the practical differences.

How I Actually Dose This for a Dog in My Exam Room

I don’t guess at joint supplement dosing, and neither should you. Follow the weight-based dosing printed on the product label — most reputable joint products are dosed by body weight in glucosamine and chondroitin milligrams, and the label reflects what was actually formulated into that batch, not a generic chart. Give it daily for a full four to six weeks before judging whether it’s working; joint supplements are not fast-acting the way an NSAID is, and expecting a one-week answer is the single most common reason owners give up on something that might have helped. If you see improvement by that point, some clinicians and labels support tapering to an every-other-day maintenance dose — but that’s a conversation to have with your own vet given your dog’s weight, kidney and liver status, and any other medications on board, not a default plan.

There’s a related decision that trips owners up just as often: format. A chew, a powder, and a liquid can all deliver the same milligrams of glucosamine and land very differently for a picky eater or a dog who spits out pills. If that’s the fork in the road you’re at, our breakdown of chew, powder, and liquid supplement forms for dogs covers what the format actually changes and where each one tends to fail in practice.

One case still sticks with me on the dosing-patience point. A Labrador mix named Duke, 11 years old, roughly 78 pounds, came in after his owner had already tried a joint chew for ten days and wanted to switch products because “nothing happened.” Duke had a documented history of mild hip dysplasia from a young age, and his owner was weighing a pricier combination product against a cheaper glucosamine-only powder, mostly on cost. We stayed the course on the original chew, added a weight-check since Duke was carrying a few extra pounds that were doing his hips no favors, and rechecked at six weeks. By then his owner reported he was taking the stairs to the bedroom again without the pause-and-think hesitation that had become his pattern. That’s one dog’s response over six weeks, not a study result, and I’m careful not to present it as one — but it’s why I push owners past the two-week mark before they write a product off.

What to Check on the Label Before You Buy Either One

Flip the bag or bottle over before you buy. Look for the actual milligrams of glucosamine and MSM per serving, not just their presence on the ingredient list — a product can legally list an ingredient without dosing it meaningfully. Check whether the glucosamine is glucosamine HCl or glucosamine sulfate, since most of the positive trial data used sulfate or a sulfate-chondroitin combination. Confirm the serving size actually matches your dog’s weight rather than a generic “for dogs” claim. And if third-party testing or NASC quality-seal information is listed, that’s worth more than a marketing claim about “vet-formulated” on the front panel, because it tells you someone checked what’s actually inside the product against what the label says.

So Which One Should You Buy First?

If I’m advising a client with a dog just starting to show mild, early joint stiffness, I default to a combination glucosamine-chondroitin product with a reasonable, labeled MSM dose alongside it — not because MSM alone has strong canine trial data, but because the strongest positive canine trial we have used a combination, and the sulfur-donor mechanism behind MSM is real enough to be a reasonable adjunct rather than a reason to wait. I don’t tell owners it will reverse arthritis. I tell them to give it six weeks, track stairs and rising-from-rest behavior the way Duke’s owner did, and loop in their vet if there’s no change by then — because at that point you’re either dealing with a supplement that isn’t working for this particular dog, or a joint problem that needs an actual diagnosis and a multimodal plan behind it.